Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16708)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 14, 2017 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gidwaney NG, Pawa S, Das KM. Pathogenesis and clinical spectrum of primary sclerosing cholangitis. World J Gastroenterol 2017; 23(14): 2459-2469 [PMID: PMC5394509 DOI: 10.3748/wjg.v23.i14.2459] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i14/2459.htm |
| Number | Citing Articles |
| 1 |
Carlo Selmi, Elena Generali, Merrill Eric Gershwin. Rheumatic Manifestations in Autoimmune Liver Disease. Rheumatic Disease Clinics of North America 2018; 44(1): 65 doi: 10.1016/j.rdc.2017.09.008
|
| 2 |
Johanna Schönau, Axel Wester, Jörn M. Schattenberg, Hannes Hagström. Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population‐based cohort study. Journal of Internal Medicine 2023; 294(2): 164 doi: 10.1111/joim.13624
|
| 3 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
| 4 |
Leilei Yu, Yaru Liu, Shunhe Wang, Qingsong Zhang, Jianxin Zhao, Hao Zhang, Arjan Narbad, Fengwei Tian, Qixiao Zhai, Wei Chen. Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies. Gut Microbes 2023; 15(1) doi: 10.1080/19490976.2023.2181930
|
| 5 |
Marco Fiore, Sebastiano Leone, Alberto Enrico Maraolo, Emilio Berti, Giovanni Damiani. Liver Illness and Psoriatic Patients. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3140983
|
| 6 |
Xiaojiaoyang Li, Runping Liu, Zhiming Huang, Emily C. Gurley, Xuan Wang, Juan Wang, Hongliang He, Hu Yang, Guanhua Lai, Luyong Zhang, Jasmohan S. Bajaj, Melanie White, William M. Pandak, Phillip B. Hylemon, Huiping Zhou. Cholangiocyte‐derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Hepatology 2018; 68(2): 599 doi: 10.1002/hep.29838
|
| 7 |
І.В. Бєлінська, Г.М. Кузнєцова, Н.В. Дзюбенко, Ю.В. Савич, Д.С. Мілохов, О.В. Хиля, Т.В. Рибальченко. Застосування 1-(4-Cl-бензил)-3-Cl-4-(CF3-феніламіно)- 1Н-пірол-2,5-діону як панспецифічного інгібітора протеїнкіназ для гальмування гематологічних ускладнень на тлі експериментального хронічного холангіту у щурів. Reports of the National Academy of Sciences of Ukraine 2021; (4): 94 doi: 10.15407/dopovidi2021.04.094
|
| 8 |
Serena Babboni, Pier Giuseppe Vacca, Ludovica Simonini, Daniele Pezzati, Caterina Martinelli, Francesco Frongillo, Giuseppe Bianco, Emanuele Marciano, Giuseppina Basta, Davide Ghinolfi, Serena Del Turco. Cholangiocyte Organoids: The New Frontier in Regenerative Medicine for the Study and Treatment of Cholangiopathies. Journal of Clinical Medicine 2024; 13(6): 1804 doi: 10.3390/jcm13061804
|
| 9 |
Nelli Sjöblom, Sonja Boyd, Hannu Kautiainen, Johanna Arola, Martti Färkkilä. Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis. Histopathology 2022; 81(2): 192 doi: 10.1111/his.14677
|
| 10 |
Xiaojiaoyang Li, Runping Liu, Yanyan Wang, Weiwei Zhu, Derrick Zhao, Xuan Wang, Hang Yang, Emily C. Gurley, Weidong Chen, Phillip B. Hylemon, Huiping Zhou. Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions. Cells 2020; 9(1): 190 doi: 10.3390/cells9010190
|
| 11 |
Qing-Ling Chen, Rui Zhong, Xiao-Xue Zhang, Li-Na Feng, Xiao-Yu Wen, Qing-Long Jin. Primary sclerosing cholangitis with increased immunoglobulin G4 levels. Medicine 2019; 98(50): e18411 doi: 10.1097/MD.0000000000018411
|
| 12 |
Raquel T. Yokoda, Elizabeth J. Carey. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. American Journal of Gastroenterology 2019; 114(10): 1593 doi: 10.14309/ajg.0000000000000268
|
| 13 |
Bettina M Buchholz, Panagis M Lykoudis, Reena Ravikumar, Joerg M Pollok, Giuseppe K Fusai. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients. World Journal of Gastroenterology 2018; 24(28): 3171-3180 doi: 10.3748/wjg.v24.i28.3171
|
| 14 |
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelación intestino-hígado. Gastroenterología y Hepatología 2019; 42(5): 316 doi: 10.1016/j.gastrohep.2019.02.004
|
| 15 |
Chris M. Li, Zhibin Chen. Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.664305
|
| 16 |
Pritee Shrestha, Philip Shara, Babajide Adio. Concomitant Pulmonary and Biliary Manifestations of Ulcerative Colitis: A Case Report. Clinical Case Reports 2025; 13(1) doi: 10.1002/ccr3.70125
|
| 17 |
Lucas Rocha ALVARENGA, Natascha Silva SANDY, Gabriela Souza GOMEZ, Gabriel HESSEL, Adriana Maria Alves DE TOMMASO, Maria Ângela BELLOMO-BRANDÃO. SYMPTOMATIC CHOLELITHIASIS AS THE PRESENTATION OF PEDIATRIC PRIMARY SCLEROSING CHOLANGITIS - CASE SERIES AND LITERATURE REVIEW. Arquivos de Gastroenterologia 2021; 58(2): 227 doi: 10.1590/s0004-2803.202100000-41
|
| 18 |
Damjana Bogatic, Robert V. Bryant, Kate D. Lynch, Samuel P. Costello. Systematic review: microbial manipulation as therapy for primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics 2023; 57(1): 23 doi: 10.1111/apt.17251
|
| 19 |
Marica Cariello, Raffaella M. Gadaleta, Antonio Moschetta. The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment. Current Opinion in Gastroenterology 2022; 38(2): 136 doi: 10.1097/MOG.0000000000000807
|
| 20 |
Jian Zhang, Huiwen Wang, Jinqing Liu, Lei Fu, Shifang Peng. ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis. Human Genomics 2023; 17(1) doi: 10.1186/s40246-023-00534-z
|
| 21 |
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Primary sclerosing cholangitis and inflammatory bowel disease: Intestine–liver interrelation. Gastroenterología y Hepatología (English Edition) 2019; 42(5): 316 doi: 10.1016/j.gastre.2019.02.030
|
| 22 |
Ji-Won Park, Jung-Hee Kim, Sung-Eun Kim, Jang Han Jung, Myoung-Kuk Jang, Sang-Hoon Park, Myung-Seok Lee, Hyoung-Su Kim, Ki Tae Suk, Dong Joon Kim. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics. Biomedicines 2022; 10(6): 1288 doi: 10.3390/biomedicines10061288
|
| 23 |
Areej Mazhar, Syed-Mohammed Jafri. Small Duct Primary Sclerosing Cholangitis. American Journal of Gastroenterology 2017; 112: S1512 doi: 10.14309/00000434-201710001-02808
|
| 24 |
Fady M Wadea. Small Duct Sclerosing Cholangitis: A Case Report and Review of Literature. Gastroenterology & Hepatology: Open Access 2017; 8(2) doi: 10.15406/ghoa.2017.08.00272
|
| 25 |
Richard Kellermayer, Marco Carbone, Thomas D. Horvath, Reka G. Szigeti, Cynthia Buness, Gideon M. Hirschfield, Peter J. Lewindon. Identifying a therapeutic window of opportunity for people living with primary sclerosing cholangitis: Embryology and the overlap of inflammatory bowel disease with immune-mediated liver injury. Hepatology 2024; doi: 10.1097/HEP.0000000000000926
|